Clinical Study Using Revolutions Medical Corporation's Proprietary MRI Software Tools Receives Investigational Review Board (IRB) Approval

Published: Jan 12, 2011

CHARLESTON, S.C., Jan. 12, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) is happy to report that it has received notice that Investigational Review Board (IRB) approval has been granted this month to the Philadelphia College of Osteopathic Medicine for the research project application titled 'Characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation,' by Dr. H. Keith Brown and his collaborators. With this new approval, the team of research scientists and clinicians will now begin collecting and analyzing diagnostic images from cases of intracranial hemorrhages using RevColor™, Rev3D™, and RevDisplay™ MRI software. The results of this important clinical study will be presented at scientific sessions throughout the country and submitted for publication in an appropriate medical image analysis related journal later this year.

Back to news